FA
Forefront Analytics Portfolio holdings
AUM
$89.5M
This Quarter Return
+6.63%
1 Year Return
+11.48%
3 Year Return
+24.94%
5 Year Return
+31.9%
10 Year Return
–
AUM
$212M
AUM Growth
+$212M
(+1.5%)
Cap. Flow
-$10.2M
Cap. Flow
% of AUM
-4.81%
Top 10 Holdings %
Top 10 Hldgs %
55.99%
Holding
71
New
3
Increased
20
Reduced
42
Closed
4
Top Buys
| 1 |
Abbott
ABT
|
$443K |
| 2 |
Nuveen ESG Large-Cap Value ETF
NULV
|
$279K |
| 3 |
Medtronic
MDT
|
$209K |
| 4 |
iShares Short Treasury Bond ETF
SHV
|
$208K |
| 5 |
Edwards Lifesciences
EW
|
$207K |
Top Sells
| 1 |
NVIDIA
NVDA
|
$1.89M |
| 2 |
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
|
$1.49M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
$1.43M |
| 4 |
JPMorgan Chase
JPM
|
$682K |
| 5 |
iShares 0-5 Year TIPS Bond ETF
STIP
|
$572K |
Sector Composition
| 1 | Healthcare | 1.71% |
| 2 | Technology | 0.89% |
| 3 | Financials | 0.33% |
| 4 | Industrials | 0.22% |
| 5 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
iShares Global REIT ETF
REET
$4B
| $354K | 0.17% |
13,261
+124
| +0.9% | +$3.31K |
|
52
RPAR Risk Parity ETF
RPAR
$523M
| $333K | 0.16% |
16,161
-238
| -1% | -$4.91K |
|
53
Regeneron Pharmaceuticals
REGN
$61.5B
| $312K | 0.15% |
297
-31
| -9% | -$32.6K |
|
54
Thermo Fisher Scientific
TMO
$186B
| $267K | 0.13% |
430
-26
| -6% | -$16.1K |
|
55
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.8B
| $232K | 0.11% |
2,889
-2,086
| -42% | -$168K |
|
|
56
Medtronic
MDT
$119B
| $209K | 0.1% |
+2,323
| New | +$209K |
|
|
57
Edwards Lifesciences
EW
$47.8B
| $207K | 0.1% |
+3,142
| New | +$207K |
|
|
MREO
58
Mereo BioPharma
MREO
$272M
| $139K | 0.07% |
33,800
-2,431
| -7% | -$9.99K |
|
59
Immatics
IMTX
$619M
| $128K | 0.06% |
11,180
-807
| -7% | -$9.21K |
|
60
Zura Bio
ZURA
$133M
| $125K | 0.06% |
30,810
-10,759
| -26% | -$43.7K |
|
61
Cogent Biosciences
COGT
$1.69B
| $108K | 0.05% |
10,021
-5,606
| -36% | -$60.5K |
|
|
KRON
62
DELISTED
Kronos Bio
KRON
| $91K | 0.04% |
90,998
-44,000
| -33% | -$44K |
|
63
Geron
GERN
$893M
| $83.9K | 0.04% |
18,491
-1,415
| -7% | -$6.42K |
|
64
Nkarta
NKTX
$151M
| $79.8K | 0.04% |
17,646
+5,813
| +49% | +$26.3K |
|
|
PSTX
65
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $79.7K | 0.04% |
27,855
-1,962
| -7% | -$5.61K |
|
66
CytomX Therapeutics
CTMX
$336M
| $70.5K | 0.03% |
59,760
-4,305
| -7% | -$5.08K |
|
67
Annexon
ANNX
$226M
| $62.1K | 0.03% |
10,483
-5,620
| -35% | -$33.3K |
|
68
Athira Pharma
ATHA
$15.3M
| – | – |
-46,595
| Closed | -$123K |
|
69
iShares Core International Aggregate Bond Fund
IAGG
$10.9B
| – | – |
-7,232
| Closed | -$361K |
|
70
Philip Morris
PM
$260B
| – | – |
-2,738
| Closed | -$278K |
|
71
Travere Therapeutics
TVTX
$1.56B
| – | – |
-13,317
| Closed | -$109K |
|